Relypsa, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2007-10-01
- Employees
- 406
- Market Cap
- -
- Website
- https://relypsa.com
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
- Conditions
- Interventions
- First Posted Date
- 2017-03-06
- Last Posted Date
- 2021-05-12
- Lead Sponsor
- Relypsa, Inc.
- Target Recruit Count
- 295
- Registration Number
- NCT03071263
- Locations
- 🇧🇬
Investigator Site 1402, Sofia, Bulgaria
🇺🇸Investigator Site 1022, Chicago, Illinois, United States
🇺🇸Investigator Site 1023, Miami Lakes, Florida, United States
Patiromer With or Without Food for the Treatment of Hyperkalemia
- First Posted Date
- 2016-02-29
- Last Posted Date
- 2021-05-12
- Lead Sponsor
- Relypsa, Inc.
- Target Recruit Count
- 114
- Registration Number
- NCT02694744
- Locations
- 🇺🇸
Investigator Site 12, Fountain Valley, California, United States
🇺🇸Investigator Site 20, Riverside, California, United States
🇺🇸Investigator Site 10, Hialeah, Florida, United States
An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis
- First Posted Date
- 2014-01-10
- Last Posted Date
- 2021-05-12
- Lead Sponsor
- Relypsa, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT02033317
- Locations
- 🇺🇸
Investigator Site, Minneapolis, Minnesota, United States
A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL)
- Conditions
- Interventions
- First Posted Date
- 2013-03-14
- Last Posted Date
- 2021-06-03
- Lead Sponsor
- Relypsa, Inc.
- Target Recruit Count
- 243
- Registration Number
- NCT01810939
- Locations
- 🇭🇷
Investigator Site 1105, Zagreb, Croatia
🇬🇪Investigator Site 1312, Tbilisi, Georgia
🇭🇷Investigator Site 1106, Zagreb, Croatia
Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)
- Conditions
- Interventions
- First Posted Date
- 2011-06-13
- Last Posted Date
- 2021-06-03
- Lead Sponsor
- Relypsa, Inc.
- Target Recruit Count
- 324
- Registration Number
- NCT01371747
- Locations
- 🇬🇪
Investigator Site 311, Tbilisi, Georgia
🇬🇪Investigator Site 303, Tbilisi, Georgia
🇬🇪Investigator Site 308, Tbilisi, Georgia
Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney Disease
- First Posted Date
- 2010-05-26
- Last Posted Date
- 2021-05-12
- Lead Sponsor
- Relypsa, Inc.
- Target Recruit Count
- 63
- Registration Number
- NCT01130597
- Locations
- 🇬🇪
Investigator Site 11, Tbilisi, Georgia
🇬🇪Investigator Site 12, Tbilisi, Georgia
🇸🇮Investigator Site 22, Maribor, Slovenia
Evaluation of Patiromer in Heart Failure Patients
- First Posted Date
- 2009-03-25
- Last Posted Date
- 2021-06-02
- Lead Sponsor
- Relypsa, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT00868439
- Locations
- 🇺🇸
Investigator Site 031, Port Charlotte, Florida, United States
🇺🇸Investigator Site 009, Peoria, Illinois, United States
🇺🇸Investigator Site 018, Minneapolis, Minnesota, United States